The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $73.00

Today's change+0.60 +0.83%
Updated November 28 1:05 PM EST. Delayed by at least 15 minutes.
 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $73.00

Today's change+0.60 +0.83%
Updated November 28 1:05 PM EST. Delayed by at least 15 minutes.

Baxter International Inc Hits New 20-day High

Baxter International Inc closed up Friday by (U.S.)$0.60 or 0.83% to (U.S.)$73.00 and setting a new 20-day high. Over the last five days, shares have gained 0.77% and 4.96% year to date. Shares have underperformed the S&P 500 by 7.40% during the last year.

Key company metrics

  • Open(U.S.) $72.82
  • Previous close(U.S.) $72.40
  • High(U.S.) $73.20
  • Low(U.S.) $72.65
  • Bid / Ask-- / --
  • YTD % change+4.96%
  • Volume1,160,271
  • Average volume (10-day)2,111,463
  • Average volume (1-month)3,131,578
  • Average volume (3-month)2,826,891
  • 52-week range(U.S.) $65.53 to (U.S.) $77.31
  • Beta0.72
  • Trailing P/E22.85×
  • P/E 1 year forward14.84×
  • Forward PEG2.40×
  • Indicated annual dividend(U.S.) $2.08
  • Dividend yield2.85%
  • Trailing EPS(U.S.) $3.20
Updated November 28 1:05 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+10.55%

Based on its net profit margin of 10.55%, Baxter International Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX1.19%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue4,1974,2643,9514,368
Total other revenue--------
Total revenue4,1974,2643,9514,368
Gross profit2,0742,1161,9731,954
Total cost of revenue2,1232,1481,9782,414
Total operating expense3,6193,5483,2403,936
Selling / general / administrative921961903982
Research & development292292282261
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)28314777279
Other operating expenses, total--------
Operating income578716711432
Interest income (expense), net non-operating-36-47-48-49
Gain (loss) on sale of assets--------
Other--------
Income before tax586661709431
Income after tax447520556326
Income tax, total139141153105
Net income468520556326
Total adjustments to net income--------
Net income before extra. items447520556326
Minority interest------0
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items447520556326
Inc. avail. to common incl. extra. items468520556326
Diluted net income468520556326
Dilution adjustment--------
Diluted weighted average shares547548548546
Diluted EPS excluding extraordinary itemsvalue per share0.820.951.010.60
Dividends per sharevalue per share0.520.520.490.49
Diluted normalized EPSvalue per share1.211.161.120.98